The role of a low dose of Propofol before awake extubation among children with upper respiratory tract infection: a prospective randomized controlled trial.

The role of a low dose of 0.5 mg/kg of Propofol before awake extubation among children with upper respiratory tract infection: a prospective randomized controlled trial.

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202412599188741

Enrollment

300

Registered

2024-12-23

Start date

2024-12-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Surgery Paediatrics Anaesthesia

Interventions

placebo group

Propofol group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: children aged under 2 months –6 years suffering from mild to modrate common cold (URTI) undergoing surgical intervention requiring general anesthesia and mechanical ventilation anesthesia duration > 30 min COLDS score < 15

Exclusion criteria

Exclusion criteria: non-operating room anesthesia severe URTI (fever>38;5) , wheezing, green runny nose, COLDS score >15

Design outcomes

Primary

Measure	Time frame
Incidence of respiratory adverse events defined by the incidence of bronchospasm, laryngospasm, airway obstruction, aspiration, or any other cause of oxygen desaturation	—

Secondary

Measure	Time frame
intensive care referral	—

Countries

Tunisia

Contacts

Public Contactkamel kolsi

anesthesiologist

kammoul.kolsi@gmail.com+21658158254

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026